Post-thyroidectomy thyroxine replacement dose in patients with or without compensated heart failure: The role of cytokines

Cytokine

Volumn 41, Issue 2, 2008, Pages 121-126

  Papanas, N ^a   Papatheodorou, K ^a   Papazoglou, D ^a   Gioka, T ^b   Antonoglou, C ^a   Kotsiou, S ^a   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cytokines; Heart failure; Hypothyroidism; Interleukin 1b; Interleukin 6; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SAMPLE SIZE; THERAPY EFFECT; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

CYTOKINES; FEMALE; HEART FAILURE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; INTERLEUKIN-6; MALE; MIDDLE AGED; REGRESSION ANALYSIS; THYROIDECTOMY; THYROXINE;

EID: 38949206872     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.10.014     Document Type: Article

References (36)

1. Woeber K.A. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med 160 (2000) 1067-1071
2. Papanas N., Papazoglou D., Papatheodorou K., Antonoglou C., Kotsiou S., and Maltezos E. Thyroxine replacement dose in patients with Hashimoto disease: a potential role for interleukin-6. Cytokine 35 (2006) 166-170
3. Kennedy R.L., and Jones T.H. Cytokines in endocrinology: their roles in health and disease. J Endocrinol 129 (1991) 167-178
4. Bethin K.E., Sherri K.V., and Muglia L.J. Interleukin-6 is an essential, corticotrophin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci USA 97 (2000) 9317-9322
5. Hidaka Y., Okumura M., Shimaoka Y., Takeoka K., Tada H., and Amino N. Increased serum concentration of interleukin-5 in patients with Grave's diasease and Hashimoto's thyroiditis. Thyroid 8 (1998) 235-239
6. Boelen A., Platvoet-Ter Schiphorst M.C., and Wiersinga W.M. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab 77 (1993) 1695-1699
7. Bartalena L., Bogazzi F., Brogioni S., Grasso L., and Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol 138 (1998) 603-614
8. Papanicolaou D.A. Euthyroid Sick Syndrome and the role of cytokines. Rev Endocr Metab Disorders 1 (2000) 43-48
9. Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., Bozkurt B., et al. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians 111 (1999) 423-428
10. Aukrust P., Ueland T., Lien E., Bendtzen K., Mulller F., Andreassen A.K., et al. Cytokine network in congestive heart failure due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83 (1999) 376-382
11. Sharma R., Al-Nasser F.O., and Anker S.D. The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure. Heart Fail Monit 2 (2001) 42-47
12. Pugh P.J., Jones R.D., Jones T.H., and Channer K.S. Heart failure as an inflammatory condition: potential role for androgens as immune modulators. Eur J Heart Fail 4 (2002) 673-680
13. Mann D.L. Inflammatory mediators and the failing heart: past, present and foreseeable future. Circ Res 91 (2002) 988-998
14. Pasic J., Levy W.C., and Sullivan M.D. Cytokines in depression and heart failure. Psychosom Med 65 (2003) 181-193
15. Damas J.K., Gullestad L., and Aukrust P. Cytokines as new treatment targets in chronic heart failure. Curr Control Trials Cardiovasc Med 2 (2001) 271-277
16. Aukrust P., Yndestad A., Damas J.K., and Gullestad L. Therapeutic potential of anticytokine therapy in congestive heart failure. Am J Cardiovasc Drugs 4 (2004) 169-177
17. Aukrust P., Yndestad A., Damas J.K., and Gullestad L. Inflammation and chronic heart failure- potential therapeutic role of intravenous immunoglobulins. Autoimmun Rev 3 (2004) 221-227
18. Bartalena L., Brogioni S., Grasso L., Rago T., Vitti P., Pinchera A., et al. Interleukin-6: a marker of thyroid-destructive processes?. J Clin Endocrinol Metab 79 (1994) 1424-1427
19. Bartalena L., Brogioni S., Grasso L., and Martino E. Interleukin-6 and the thyroid. Eur J Endocrinol 132 (1995) 386-393
20. Jones T.H., Kennedy R.L., Justice S.K., and Davies R. Effect of glucocorticoids and oestrogen on interleukin-6 production by human thyrocytes from patients with Graves' disease and toxic multinodular goitre and from HTori3 cells. Eur J Endocrinol 137 (1997) 429-432
21. Bartalena L., Brogioni S., Grasso L., Veluzzi F., and Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 17 (1994) 269-274
22. Hashimoto H., Igarashi N., Yachie A., Miyawaki T., and Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 78 (1994) 288-291
23. Stouthard J.M.L., van der Poll T., Endert E., Bakker P.J.M., Veenhof C.H.N., Sauerwein H.P., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 79 (1994) 1342-1346
24. Torpy D.J., Tsigos C., Lotsikas A.J., Defensor R., Chrousos G.P., and Papanicolaou D.A. Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism 47 (1998) 1289-1293
25. De Groot L.J. Dangerous dogmas in medicine: the Nonthyroidal Illness Syndrome. J Clin Endocrinol Metab 84 (1999) 151-164
26. Kelly G. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev 5 (2000) 306-333
27. Yu J., and Koenig R.J. Regulation of hepatocyte thyroxine 5'-deiodinase by T3 and nuclear receptor coactivators as a model of the Sick Euthyroid Syndrome. J Biol Chem 275 (2000) 38296-38301
28. Boelen A., Maas M.A.W., Lowik C.W.G.M., Platvoet M.C., and Wiersinga W.M. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology 137 (1996) 5250-5254
29. Kimura T., Kanda T., Kotajima N., Kuwabara A., Fukumura Y., and Kobayashi I. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur J Endocrinol 143 (2000) 179-184
30. Kimura T., Kotajima N., Kanda T., Kuwabara A., Fukumura Y., and Kobayashi I. Correlation of circulating interleukin-10 with thyroid hormone in acute myocardial infarction. Res Commun Mol Pathol Pharmacol 110 (2001) 53-58
31. Pavlou H.N., Kliridis P.A., Panagiotopoulos A.A., Goritsas C.P., and Vassilakos P.J. Euthyroid sick syndrome in acute ischemic syndrome. Angiology 53 (2002) 699-707
32. Van der Poll T., Romijn J.A., Wiersinga W.M., and Sauerwein H.P. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71 (1990) 1567-1572
33. Molnár I., Balázs C., Szegedi G., and Sipka S. Inhibition of type 2,5'-deiodinase by tumor necrosis factor alpha, interleukin-6 and interferon gamma in human thyroid tissue. Immunol Lett 80 (2002) 3-7
34. Shalaby M.R., Waage A., and Espevik T. Cytoikine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 121 (1989) 372-382
35. Shalaby M.R., Waage A., Aarden L., and Espevik T. Endotoxin, tumor necrosis -alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol 53 (1989) 488-498
36. Chopra I.J., Sakane S., and Chua Teco G.N. A study of the serum concentration of tumor necrosis factor-α in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 72 (1991) 1113-1116